Status:
UNKNOWN
the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-60 years
Phase:
PHASE4
Brief Summary
The aim of this study is the comparision between the effects of vitamin D or placebo supplementation for 2 months in serum level of thioredoxin, TBP-2 and thioredoxin reductase activity in patients wi...
Eligibility Criteria
Inclusion
- literate, willingness to participation, diabetic patients 30- 60 years old, body mass index in the range 18.5- 35, avoidance of dietary supplements, vitamins and herbal products at least 3 months before and throughout the intervention -
Exclusion
- people who have used vitamin D supplements in last 3 months, having chronic renal disease , GI disease, Hepatobilliary diseases, hematological disorders, hypo- or hyperthyroidism, treatment with orlistat or sibutramine for weight loss, pregnancy and lactation, treatment with insulin or Thiazolidinediones, Smokers
- \-
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01876563
Start Date
August 1 2012
End Date
July 1 2014
Last Update
June 12 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University of Medical Sciences
Tehran, Tehran Province, Iran
2
Tehran University of Medical Sciences
Tehran, Iran